14 results
8-K
EX-99.1
RVLPQ
RVL Pharmaceuticals plc
8 Sep 21
Other Events
6:22am
of operations and financial condition.
There has also been increasing U.S. federal and state enforcement interest with respect to drug pricing. In addition
8-K
EX-99.1
RVLPQ
RVL Pharmaceuticals plc
31 Jul 20
Is (I) Not Material and (Ii) Would Likely Cause Competitive Harm to the Company If
4:33pm
conditions are subject to the effects of changes in regulations made by the governments of Japan and other nations concerning medical insurance, drug … pricing and other systems, and to fluctuations in market variables such as interest rates and foreign exchange rates.
Osmotica Forward-looking
424B4
c2jz4bt9b5m
10 Jan 20
Prospectus supplement with pricing info
4:19pm
10-K
d0klt7cr exsiuh2c02
28 Mar 19
Annual report
12:00am
424B4
h39 fqg89imbadlko722
19 Oct 18
Prospectus supplement with pricing info
4:15pm
DRS/A
08lsoo9h6cqmj29 8xbl
20 Jun 18
Draft registration statement (amended)
12:00am
DRS
c01fok5kdse
9 May 18
Draft registration statement
12:00am
- Prev
- 1
- Next